AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2021
May 20, 2021
35424_dirs_2021-05-20_df46ecde-831d-499c-8f4b-9609c5ed2091.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2021-05-17
Reporting Person: Cuvelier Chris (Chief Growth Officer)
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 6
Regulatory Filings
2026
Jan 28
Regulatory Filings
2026
Jan 14
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 29
Regulatory Filings
2025
Dec 23
Annual Report
2025
Nov 19